Mycobacterium vaccae Nebulization in the Treatment of COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial-Reference-Cited by-同舟云学术

Mycobacterium vaccae Nebulization in the Treatment of COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial

Published:2021-04-01 Issue:2 Volume:34 Page:108-114
ISSN:1941-2711
Container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery
language:en
Short-container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery

Author:

Lin Yan-rong¹,Wu Feng-yao¹,Xiao Huan²,Huang Jian-lin²,Gong Bei-bei¹,Li You-ling¹,Lu Ning¹,Jiang Xiao-hong²,Sun Qi-xiang²,Zhang Jian-feng³,Hu Jun-tao²,Zhao Yong-xiang⁴,Li Chao-qian²

Affiliation:

1. Department of Respiratory and Critical Care Medicine, The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.

2. Department of Respiratory Medicine, Guangxi Medical University, Nanning, Guangxi, China.

3. Department of Emergency, Guangxi Medical University, Nanning, Guangxi, China.

4. Collaborative Innovation Center for Targeting Tumor Theranostics, Guangxi Medical University, Nanning, Guangxi, China.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmaceutical Science,Pulmonary and Respiratory Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/jamp.2020.1628

Reference28 articles.

1. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

2. Clinical Characteristics of Coronavirus Disease 2019 in China

3. The Novel Coronavirus Originating in Wuhan, China

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-acting inhaled medicines: Present and future;Advanced Drug Delivery Reviews;2024-01

2. Incidence of Stroke in Randomized Trials of COVID-19 Therapeutics: A Systematic Review and Meta-Analysis;Stroke;2022-11

3. Nebulizer systems: a new frontier for therapeutics and targeted delivery;Therapeutic Delivery;2022-01